Inventor
OTTOW ECKHARD
DE39 patents
⚠️ This page may combine multiple inventors who share the name “OTTOW ECKHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
32 patentsUS5089488AFeb 18, 1992
β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
SCHERING AG44 citations96
US4814327AMar 21, 1989
11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
SCHERING AG49 citations96
US6025376AFeb 15, 2000
Chiral methylphenyloxazolidinones
SCHERING AG32 citations92
US5843931ADec 1, 1998
6,7-modified 11β-aryl-4-oestrenes
SCHERING AG21 citations92
US5843933ADec 1, 1998
11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG31 citations92
US5728689AMar 17, 1998
11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG18 citations92
US5446036AAug 29, 1995
13-alkyl-11beta-phenylgonanes
SCHERING AG32 citations92
US5273971ADec 28, 1993
13-alkyl-11β-phenylgonanes
SCHERING AG26 citations92
US5244886ASep 14, 1993
11β-phenyl-14βH steroids
SCHERING AG27 citations92
US5095129AMar 10, 1992
19,11 β-bridged steroids, their manufacture and pharmaceutical preparations containing them
SCHERING AG31 citations92
US4829060AMay 9, 1989
11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and pharmaceutical preparations containing them
SCHERING AG32 citations92
US4870069ASep 26, 1989
11β-alkynyl-estrenes and -estradienes, their production and pharmaceutical preparations containing them
SCHERING AG27 citations91
US5439913AAug 8, 1995
Contraception method using competitive progesterone antagonists and novel compounds useful therein
SCHERING AG26 citations89
US5426102AJun 20, 1995
14β-H-, 14-and 15-En-11β-aryl-4-oestrenes
SCHERING AG20 citations83
US5132299AJul 21, 1992
11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same
SCHERING AG21 citations82
US5446178AAug 29, 1995
Process for preparing 19,11β-bridged steroids
SCHERING AG9 citations74
US5405979AApr 11, 1995
Process for the production of 10β-H-steroids
SCHERING AG15 citations74
US5232915AAug 3, 1993
9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids
SCHERING AG14 citations74
US6790853B2Sep 14, 2004
Contraception method using competitive progesterone antagonists and novel compounds useful therein
SCHERING AG3 citations73
US6608074B2Aug 19, 2003
Contraception method using competitive progesterone antagonists and novel compounds useful therein
SCHERING AG9 citations73
US6340688B1Jan 22, 2002
Contraception method using competitive progesterone antagonists and novel compounds useful therein
SCHERING AG5 citations73
US5093507AMar 3, 1992
10β,11β-bridged steroids
SCHERING AG15 citations73
US6143733ANov 7, 2000
Quinoxalinedione derivatives, their production and use in pharmaceutical agents
SCHERING AG7 citations72
US5519027AMay 21, 1996
D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG5 citations63
US5523298AJun 4, 1996
Progestationally active 19,11-bridged 4-estrenes
SCHERING AG4 citations62
US5359054AOct 25, 1994
Initial compounds for the production of 10β-H-steroids and a process for the production of these initial compounds
SCHERING AG4 citations60
US6596713B1Jul 22, 2003
Steroid esters and amides, process for their production and their pharmaceutical use
SCHERING AG2 citations57
US7321044B2Jan 22, 2008
Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
SCHERING AG2 citations55
US7297702B2Nov 20, 2007
Contraception method using competitive progesterone antagonists and novel compounds useful therein
SCHERING AG0 citations52
US6096732AAug 1, 2000
Steroid esters, process for their production and their pharmaceutical use
SCHERING AG0 citations52
US5703066ADec 30, 1997
Progestationally active 19,11-bridged 4-estrenes
SCHERING AG1 citations51
US6127368AOct 3, 2000
Anellated β-carbolines
SCHERING AG0 citations39
NOVARTIS AG
3 patentsUS7122547B1Oct 17, 2006
Anthranilic acid amides and the use thereof as medicaments
NOVARTIS AG79 citations97
US6818661B2Nov 16, 2004
Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors
NOVARTIS AG21 citations92
US7479491B2Jan 20, 2009
Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors
NOVARTIS AG0 citations52